Resource Library

Discover Kymera’s research and resources on our exciting platform, pipeline, and additional cutting-edge technologies.

  • Programs & Targets

  • Indications

  • Year

  • Resource Type/Format

  • Development Stage

Related Resources

July 24, 2023

Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders

Gadiyar, V., Patel, G., Chen, J., Vigil, D., Ji, N., Campbell, V., Sharma, K., Shi, Y., Weiss, M., Birge, R., & Davra, V.
Read More
December 7, 2022

Proteomics enabling TPD Drug Discovery

TPD Assay Development and Screening Summit
Read More
October 25, 2022

Expression & Characterization of Novel Tissue Selective E3 Ligases

5th Annual Targeted Protein Degradation (TPD) Summit
Read More
August 15, 2022

MQAtlas Creates a Deep, Accurate and Global E3 Expression Atlas Enabling Targeted Protein Degradation Based Precision Medicine

The 14th International Symposium on Mass Spectrometry in the Health and Life Sciences
Read More
June 6, 2022

Discovery and targeted mass spectrometry-based proteomics: Enabling technologies advancing IRAK4 protein degrader along the drug discovery pipeline into the clinic

The American Society for Mass Spectrometry (ASMS) Annual Conference
Read More
April 27, 2022

Drugging Tissue Restricted E3 Ligases for TPD-based Precision Medicine

2nd Annual Ligase Targeting Drug Development Summit
Read More
April 26, 2022

Chemically Harnessing Novel E3 Ligases Biology for Next-generation TPD Therapeutics

2nd Annual Ligase Targeting Drug Development Summit
Read More
October 28, 2021

Considerations for E3 Ligase Pairing and Screening of Immune-Inflammation Targets

4th Annual TPD Summit
Read More
October 27, 2021

Understanding PK/PD for Development of STAT3 Degraders in Oncology Indications

4th Annual TPD Summit
Liquid Tumors Solid Tumors
Read More
May 26, 2021

Drugging Tissue-Restricted E3 Ligases

Ligase Targeting Drug Development Summit
Read More